Sildenafil had a 55% reduced risk of the condition contrasted to losartan, 63% compared to metformin, 65% compared to diltiazem and 64% contrasted to glimepiride. They discovered sildenafil customers were 69% less likely to establish Alzheimer's disease than non-sildenafil users after 6 years of follow-up. The characteristics of advertisement https://viagracokr.com